Public Consultation in the EU on ICH Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management [read more]
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions